Clinical-stage biopharmaceutical company developing proprietary fusion-compound immunotherapies for autoimmune and other proinflammatory diseases, cancer, and senescence-associated dysplasia
Clinical-stage biopharmaceutical company developing proprietary fusion-compound immunotherapies for autoimmune and other proinflammatory diseases, cancer, and senescence-associated dysplasia. It also commercializes reagents used in producing immunotherapeutics, including support for CAR-T cell production.